BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1314703)

  • 1. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product.
    Ibáñez CF; Ebendal T; Barbany G; Murray-Rust J; Blundell TL; Persson H
    Cell; 1992 Apr; 69(2):329-41. PubMed ID: 1314703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors.
    Mahadeo D; Kaplan L; Chao MV; Hempstead BL
    J Biol Chem; 1994 Mar; 269(9):6884-91. PubMed ID: 8120051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J; Vroegop SM; Buxser SE; Neet KE
    J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation.
    Berg MM; Sternberg DW; Hempstead BL; Chao MV
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7106-10. PubMed ID: 1714587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells.
    Kahle P; Barker PA; Shooter EM; Hertel C
    J Neurosci Res; 1994 Aug; 38(5):599-606. PubMed ID: 7815475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor.
    Hempstead BL; Martin-Zanca D; Kaplan DR; Parada LF; Chao MV
    Nature; 1991 Apr; 350(6320):678-83. PubMed ID: 1850821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis.
    Jiang H; Movsesyan V; Fink DW; Fasler M; Whalin M; Katagiri Y; Monshipouri M; Dickens G; Lelkes PI; Guroff G; Lazarovici P
    J Cell Biochem; 1997 Aug; 66(2):229-44. PubMed ID: 9213224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.
    Kaplan DR; Hempstead BL; Martin-Zanca D; Chao MV; Parada LF
    Science; 1991 Apr; 252(5005):554-8. PubMed ID: 1850549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor.
    Meakin SO; Suter U; Drinkwater CC; Welcher AA; Shooter EM
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2374-8. PubMed ID: 1312719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of NH2-terminal residues of nerve growth factor affects activity and Trk binding without affecting stability or conformation.
    Woo SB; Timm DE; Neet KE
    J Biol Chem; 1995 Mar; 270(11):6278-85. PubMed ID: 7890765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
    Kullander K; Ebendal T
    J Neurosci Res; 1994 Oct; 39(2):195-210. PubMed ID: 7837289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activity.
    Shih A; Laramee GR; Schmelzer CH; Burton LE; Winslow JW
    J Biol Chem; 1994 Nov; 269(44):27679-86. PubMed ID: 7961687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor binds to the 140 kd trk proto-oncogene product and stimulates its association with the src homology domain of phospholipase C gamma 1.
    Ohmichi M; Decker SJ; Pang L; Saltiel AR
    Biochem Biophys Res Commun; 1991 Aug; 179(1):217-23. PubMed ID: 1715690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trk proto-oncogene encodes a receptor for nerve growth factor.
    Klein R; Jing SQ; Nanduri V; O'Rourke E; Barbacid M
    Cell; 1991 Apr; 65(1):189-97. PubMed ID: 1849459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ hybridization detection of trkA mRNA in brain: distribution, colocalization with p75NGFR and up-regulation by nerve growth factor.
    Gibbs RB; Pfaff DW
    J Comp Neurol; 1994 Mar; 341(3):324-39. PubMed ID: 8195465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
    Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
    Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth.
    Ashcroft M; Stephens RM; Hallberg B; Downward J; Kaplan DR
    Oncogene; 1999 Aug; 18(32):4586-97. PubMed ID: 10467403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational studies of conserved residues in the dimer interface of nerve growth factor.
    Guo M; Meyer SL; Kaur H; Gao JJ; Neet KE
    Protein Sci; 1996 Mar; 5(3):447-55. PubMed ID: 8868481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
    Pflug BR; Dionne C; Kaplan DR; Lynch J; Djakiew D
    Endocrinology; 1995 Jan; 136(1):262-8. PubMed ID: 7828539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.